KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Inventory (2016 - 2025)

Historic Inventory for Cvs Health (CVS) over the last 17 years, with Q4 2025 value amounting to $19.2 billion.

  • Cvs Health's Inventory rose 629.04% to $19.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $19.2 billion, marking a year-over-year increase of 629.04%. This contributed to the annual value of $19.2 billion for FY2025, which is 629.04% up from last year.
  • Per Cvs Health's latest filing, its Inventory stood at $19.2 billion for Q4 2025, which was up 629.04% from $19.0 billion recorded in Q3 2025.
  • In the past 5 years, Cvs Health's Inventory registered a high of $19.2 billion during Q4 2025, and its lowest value of $16.1 billion during Q2 2024.
  • Moreover, its 5-year median value for Inventory was $17.7 billion (2021), whereas its average is $17.8 billion.
  • Its Inventory has fluctuated over the past 5 years, first crashed by 1049.66% in 2024, then surged by 858.23% in 2025.
  • Cvs Health's Inventory (Quarter) stood at $17.8 billion in 2021, then grew by 7.49% to $19.1 billion in 2022, then dropped by 5.58% to $18.0 billion in 2023, then increased by 0.45% to $18.1 billion in 2024, then increased by 6.29% to $19.2 billion in 2025.
  • Its last three reported values are $19.2 billion in Q4 2025, $19.0 billion for Q3 2025, and $17.4 billion during Q2 2025.